Middle Molecule Find

Rulebook › V-tags › V383

V383 Reporting adverse outcomes

Written V0383 on the CMS-2567 and in QCOR.

Enforces 42 CFR 494.50(c)(2)(iii) · Appendix H Rev. 246, page 185 · checked 12 Nov 2026

Cited on this tag? What happens after a citation · One-page sheet for the binder

The regulation

§ 494.50(c)(2) – When clinically indicated (for example, after adverse patient reactions), the facility must – (iii) Report the adverse outcomes to the FDA and other Federal, State or local government agencies as required by law.

Read 42 CFR 494.50 on the eCFR

CMS's interpretive guidance

Interpretive Guidance § 494.50(c)(2)(iii)

The dialyzer manufacturer may or may not be responsible for reporting adverse outcomes related to reprocessing/reuse, depending on their legal liabilities. This regulation, however, requires the facility to be responsible for reporting any adverse outcomes potentially related to reprocessing/reuse, as required by law. Facility policy should address adverse occurrence reporting.

Verbatim from Appendix H Rev. 246, with CMS's headings, lists and bold. Check page 185 (the full 469-page PDF) before quoting it.

Connected tags

Tags whose guidance points here